Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease

Abstract

<jats:p>Life expectancy has gradually grown over the last century. This has deeply affected healthcare costs, since the growth of an aging population is correlated to the increasing burden of chronic diseases. This represents the interesting challenge of how to manage patients with chronic diseases in order to improve health care budgets. Effective primary prevention could represent a promising route. To this end, precision, together with personalized medicine, are useful instruments in order to investigate pathological processes before the appearance of clinical symptoms and to guide physicians to choose a targeted therapy to manage the patient. Cardiovascular and neurodegenerative diseases represent suitable models for taking full advantage of precision medicine technologies applied to all stages of disease development. The availability of high technology incorporating artificial intelligence and advancement progress made in the field of biomedical research have been substantial to understand how genes, epigenetic modifications, aging, nutrition, drugs, microbiome and other environmental factors can impact health and chronic disorders. The aim of the present review is to address how precision and personalized medicine can bring greater clarity to the clinical and biological complexity of these types of disorders associated with high mortality, involving tremendous health care costs, by describing in detail the methods that can be applied. This might offer precious tools for preventive strategies and possible clues on the evolution of the disease and could help in predicting morbidity, mortality and detecting chronic disease indicators much earlier in the disease course. This, of course, will have a major effect on both improving the quality of care and quality of life of the patients and reducing time efforts and healthcare costs.</jats:p>

Angiotensin System Polymorphisms’ in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study

“…The study/analysis of SNPs finds applications in the field of diagnostic (differential diagnosis), giving clinicians the ability to identify individual susceptibilities to numerous diseases and responses to drugs, including side effects and toxic reactions (pharmacogenomics). 43 …”

Multidisciplinary Effort to Drive Precision-Medicine for the Future

“…In general, PM can be regarded as the use of technical means to analyze big data of healthy populations and patients with specific disease(s) to achieve precise prediction, diagnosis, and treatment of specific subgroups of patients. Unlike personalized medicine, which pays more attention to individuals, PM mainly focuses on the stratification of patients with seemingly similar disease, e.g., diabetes, into subpopulations of patients based on disease mechanism to develop targeted therapeutic strategies ( 3 ). In recent years, with the development of big data and AI, the establishment of PM programs in various countries has also developed rapidly.…”

“…It is not a new term and concepts similar to PM have surfaced since ancient times ( 2 ). As early as the last century, the idea of personalized medicine, a concept similar to PM but more focused on the individual, has come to attention ( 3 ). In the 1960s and 1970s, people have already realized the importance of providing the right drug for the right patient ( 4 ).…”

Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health

“…The Human Genome Project and the increased use of the omics approach in nutrition science have led researchers to focus on personalized nutrition in order to improve the impact of diet on health status and wellbeing, taking into account individual genetic factors and epigenetic signatures [ 93 ]. Precision and personalized medicine are useful tools for preventive strategies and could help with predicting morbidity and mortality and detecting chronic disease much earlier in the disease course, to improve the quality of care and quality of life of the patients and reduced healthcare time, efforts, and costs [ 94 ]. It is well established that environmentally related diseases are the result of the “exposome”—the totality of exposure experienced by an individual during life and the health impact of those exposures [ 95 ].…”